Evidence map›Paper›PMID 38222068›Full record

ArticleJournal of the Royal Statistical Society. Series C, Applied statistics2024

Models and methods for analysing clustered recurrent hospitalisations in the presence of COVID-19 effects.

Xuemei Ding, Kevin He, John D Kalbfleisch

Open access · hybridAbstract read
In one paragraph

Article in Journal of the Royal Statistical Society. Series C, Applied statistics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xuemei DingDepartment of Biostatistics, University of Michigan, Ann Arbor, USA.
Kevin HeDepartment of Biostatistics, University of Michigan, Ann Arbor, USA.ORCID https://orcid.org/0000-0002-8354-426X
John D KalbfleischDepartment of Biostatistics, University of Michigan, Ann Arbor, USA.ORCID https://orcid.org/0000-0001-9198-9667
University of Michigan · US

Funding

Survival Analysis Methods for Organ Failure DataR01DK070869 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DOUGLAS EARL SCHAUBEL · 2005 to 2026
$4.7M
Improve Statistical Methods for Profiling of Healthcare ProvidersR01DK129539 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Zhi Kevin He · 2022 to 2026
$1.6M
NIDDK NIH HHS R01 DK070869NIDDK NIH HHS R01 DK129539
6 · The paper itself

Abstract

Recurrent events such as hospitalisations are outcomes that can be used to monitor dialysis facilities' quality of care. However, current methods are not adequate to analyse data from many facilities with multiple hospitalisations, especially when adjustments are needed for multiple time scales. It is also controversial whether direct or indirect standardisation should be used in comparing facilities. This study is motivated by the need of the Centers for Medicare and Medicaid Services to evaluate US dialysis facilities using Medicare claims, which involve almost 8,000 facilities and over 500,000 dialysis patients. This scope is challenging for current statistical software's computational power. We propose a method that has a flexible baseline rate function and is computationally efficient. Additionally, the proposed method shares advantages of both indirect and direct standardisation. The method is evaluated under a range of simulation settings and demonstrates substantially improved computational efficiency over the existing

Indexed as

direct standardisationindirect standardisationlarge databaseproportional ratesprovider profilingtime-varying covariates

Identifiers

PMID38222068
PMCPMC10782460
OpenAlexW4386469376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.